Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Kranker Larsen

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
JAMA Dermatology|May 6, 2026
Interpreting Community-Based Remission and Progression Rates in Hidradenitis Suppurativa-ReplyRune Kjærsgaard Andersen, Morten Kranker Larsen, Christina Ellervik
British Journal of Haematology|November 14, 2023
Proof of concept of triple COMBI therapy to prohibit MPN progression to AMLHans Carl Hasselbalch, Vibe Skov, Lasse Kjaer, et al.
Advances in Hematology|August 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical TrialsSophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen, et al.
British Journal of Haematology|July 23, 2025
Prevalence and impact of additional CHIP mutations in JAK2V617F-positive ischaemic cerebrovascular patientsMarie Hvelplund Kristiansen, Vibe Skov, Morten Kranker Larsen, et al.
Cancers|November 26, 2022
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and PerspectivesHans Hasselbalch, Vibe Skov, Lasse Kjær, et al.
Blood Advances|July 31, 2023
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control studyMarie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, et al.
Blood Advances|December 22, 2023
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbiditiesHans Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjær, et al.
Annals of Hematology|April 18, 2024
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySophie Thau, Christian Bjørn Poulsen, Christian Brieghel, et al.
Plos One|June 30, 2022
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanismsVibe Skov, Mads Thomassen, Lasse Kjær, et al.
European Journal of Haematology|August 28, 2023
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasmsVibe Skov, Mads Thomassen, Lasse Kjaer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
JAMA Dermatology|May 6, 2026
Interpreting Community-Based Remission and Progression Rates in Hidradenitis Suppurativa-ReplyRune Kjærsgaard Andersen, Morten Kranker Larsen, Christina Ellervik
British Journal of Haematology|November 14, 2023
Proof of concept of triple COMBI therapy to prohibit MPN progression to AMLHans Carl Hasselbalch, Vibe Skov, Lasse Kjaer, et al.
Advances in Hematology|August 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical TrialsSophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen, et al.
British Journal of Haematology|July 23, 2025
Prevalence and impact of additional CHIP mutations in JAK2V617F-positive ischaemic cerebrovascular patientsMarie Hvelplund Kristiansen, Vibe Skov, Morten Kranker Larsen, et al.
Cancers|November 26, 2022
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and PerspectivesHans Hasselbalch, Vibe Skov, Lasse Kjær, et al.
Blood Advances|July 31, 2023
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control studyMarie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, et al.
Blood Advances|December 22, 2023
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbiditiesHans Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjær, et al.
Annals of Hematology|April 18, 2024
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySophie Thau, Christian Bjørn Poulsen, Christian Brieghel, et al.
Plos One|June 30, 2022
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanismsVibe Skov, Mads Thomassen, Lasse Kjær, et al.
European Journal of Haematology|August 28, 2023
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasmsVibe Skov, Mads Thomassen, Lasse Kjaer, et al.
Pageof 4